Found 5 matching trials
Hib-MenCY-TT Vaccine Study Compared to Licensed Hib and Meningococcal Serogroup C Conjugate Vaccines PHASE2 This study is evaluating the safety and immunogenicity of Hib-MenCY-TT vacc...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Immunogenicity, Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Hib-MenCY-TT (MenHibrix®) Vaccine Compared to Merck & Co, Inc. PedvaxHIB Vaccine in Healthy Infants and Toddlers 12 to 15 Months of Age PHASE3 The purpose of this study is to evaluate the safety, reactogenicity and imm...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Study of PR5I, a Pediatric Combination Vaccine With Enhanced Hepatitis B Component Given Concomitantly With Prevnar® PHASE2 PR5I, a hexavalent pediatric combination vaccine is being developed to redu...
Show More Location
Multiple Locations
Learn More & Join Trial
Surveillance Program to Determine Product Specific Rates of Invasive Hib Disease N/A To monitor the occurrence of invasive Hib disease over time and to determin...
Show More Location
Multiple Locations
Learn More & Join Trial
Evaluation of a Vaccine for Reducing Ear and Lung Infections in Children PHASE2 The purpose of this study is to 1) demonstrate the protective efficacy agai...
Show More Location
GSK Investigational Site
Learn More & Join Trial